Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics Munich, |
RCV000578314 | SCV000680272 | pathogenic | Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability | 2017-10-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001726201 | SCV001961239 | pathogenic | not provided | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001726201 | SCV003439556 | pathogenic | not provided | 2022-09-28 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 435616). This variant has been observed in individual(s) with KIF11-related conditions (PMID: 25934493, 31130284, 33619735). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change affects codon 974 of the KIF11 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the KIF11 protein. This variant also falls at the last nucleotide of exon 20, which is part of the consensus splice site for this exon. |
Genetic Services Laboratory, |
RCV000504431 | SCV000595375 | uncertain significance | not specified | 2017-02-08 | flagged submission | clinical testing | |
Service de Génétique Moléculaire, |
RCV000578314 | SCV001432352 | pathogenic | Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability | no assertion criteria provided | clinical testing |